Received: 16 November 2020
Accepted: 16 February 2021
First Online: 16 March 2021
Ethics approval and consent to participate
: <b>Informed consent</b> was obtained for all participants for which tumour blocks were included. Ethics approval was granted by the local ethics committee of the University hospital of Guadeloupe approval n° A21_02_05_17, and the study complies with the Declaration of Helsinki ethical standards. Data produced for this study was anonymized prior to analysis by investigators. The Guadeloupe cancer registry and Karubiotec™ are authorized by the National Authority for the protection of privacy and personal data (Commission Nationale de l’Informatique et des Libertés, CNIL) to carry out this study.
: Our manuscript does not contain any individual person’s data in any form.
: The authors declared that they have no conflict of interest.